organ transplantation

27
Assoc. Prof. Ma. Jennifer R. Tiburcio, MSMT Department of Med Tech UST Faculty of Pharmacy

Upload: regrine-lagarteja

Post on 28-Oct-2014

56 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Organ Transplantation

Assoc. Prof. Ma. Jennifer R. Tiburcio, MSMT

Department of Med Tech

UST Faculty of Pharmacy

Page 2: Organ Transplantation

Grafting Transfer of cells One part of the body to another One individual to another

Transferred material (graft)

Page 3: Organ Transplantation

TERM SOURCE OF TISSUE

EXAMPLES

Autograft Tissue is from the recipient

Autologous skin grafting, bone marrow transplants

Syngraft (Isograft)

Tissue from a genetically identical individual, i.e. identical twin

Kidney transplant, bone marrow transplant

Allograft (Homograft)

Tissue from a genetically distinct individual of the same species

Most organ transplants: kidney, heart, lungs, etc.

Xenograft (Heterograft)

Material from an animal of a different species

Baboon heart transplanted into a human

 

Page 4: Organ Transplantation
Page 5: Organ Transplantation

Physical Placement1. Orthotopic – same place2. Heterotropic – different site

Growth Properties of graft1. Homostatic – no occurrence of growth

of the transplanted graft 2. Homovital – occurrence of tissue growth

after transplantation

Page 6: Organ Transplantation

Most immunogenic

Bone marrow

Skin

Islet of langerhans

Heart

Transplant TissueTransplant Tissue

Page 7: Organ Transplantation

Kidneys

Liver

Bone

Xenogeneic valve replacement

Least immunogenic

Cornea

Page 8: Organ Transplantation

TYPE OF TISSUE

TIME OF TISSUE

DAMAGE

MECHANISM CAUSE

Hyperacute W/in minutes Humoral Preformed cytotoxic antibodies to donor antigen

Accelerated 2 to 5 days Cellular Previous sensitization to donor antigen

Acute 7 to 21 days Cellular (ADCC) Development of allogeneic rxn to donor antigen

Chronic Later than 3 months

Cellular Disturbance of host/graft tolerance

Immunopatholo-gic damage to the new organ

Later than 3 months

1. immune complex disorder2. complex formation w/ soluble antigen

Immunopathologic mechanisms rela-ted to circumstan- ces necessitating transplant

 

Page 9: Organ Transplantation

CornealDoes not evoke rejection

Tissue does not come in contact with the immunologic system

BoneProvide mechanical function

and supportEthylene oxide or gamma radiation

Page 10: Organ Transplantation

Kidney

ABO & HLACadaveric transplantation

Number of mismatches is zero or one

Liver, heart & Lungs

Problem – difficulty in detecting rejection episodes

Page 11: Organ Transplantation

Heart

Transplanted within 4 hrsProspective matching

DNA typingDonors & recipients –ABO &

size of the organs

Pancreas

Islet cells – life-enhancingABO blood groupingTissue crossmatching

Matching of HLA-DR antignes

Page 12: Organ Transplantation

HLA – more crucialRegenerate replacement marrow w/in 8 weeks

High doses of chemotherapy or radiation- to prevent rejection

Destroy any residual cancer cellsProvide space for the new marrow to grow

Bone marrow

Page 13: Organ Transplantation

Graft-versus-host Graft-versus-host (GVH disease)(GVH disease)

Occurs when grafted immunocompetent cells from a donor mount an IR against the host tissues

Matching of the HLA-A & B and HLA-DwUse of methotrexate & cyclosporin has greatly

reduced the occurrence of this phenomenon

Page 14: Organ Transplantation

Host- Versus- Graft Reaction

Graft- Versus- Host Reaction

HOST RESPONSE TO HOST RESPONSE TO TRANSPLANTATIONTRANSPLANTATION

Page 15: Organ Transplantation

In Organ Transplantation: foreign HLA molecules of the graft serve as ligands (targets) for T cell receptors in the recipient, initiating an inflammatory response that leads to loss of graft function.

= GRAFT REJECTIONGRAFT REJECTION

Page 16: Organ Transplantation

Graft- Versus- Host Graft- Versus- Host ReactionReaction

Page 17: Organ Transplantation

Graft- Versus- Host Graft- Versus- Host ReactionReaction

Common manifestations:– Diarrhea– Erythema– Weight loss– Malaise– Fever– Joint pains– Death

Page 18: Organ Transplantation
Page 19: Organ Transplantation
Page 20: Organ Transplantation
Page 21: Organ Transplantation

Lymphocytotoxicity TestLymphocytotoxicity Test

Used for the serological detection of MHC class 1 & class II antigens.

Once a donor has been selected, the match is confirmed by using donor’s cell &recipients serum in a repeat lymphocytotoxicity test.

If the patient’s serum is cytotoxic or the donor’s cells the transplant is not performed.

Page 22: Organ Transplantation

Patients lymphocytes

incubateReagent Antibody

Add C’

Tryptan bluedye

Live cells take up no dye=Negative for that HLA Ag

Dead cells take up dye= positive for that HLA antigen

c

c

incubate

+ C’

Page 23: Organ Transplantation

Mixed leukocyte reactionMixed leukocyte reaction

Detects the degree of immune cellular stimulation of the recipient’s T lymphocytes by donor cells.

Page 24: Organ Transplantation

DonorLymphoctes +Recipients lymphocytes Tritiated

Day 5 Count radioactivity in cells

Lymphocyte are isolated from the whole blood of both the donor &the recipient using Ficoll-Hypaque centrifugation.The lymphocytes are incubated together at 37degrees Celsius for 5 days.

Page 25: Organ Transplantation

Antigen Non-specific

Drugs: Azathioprine

Steroids

Cyclosporine

Anti-lymphocyte globulin

Radiation

Immunosuppressive TreatmentsImmunosuppressive Treatments

Page 26: Organ Transplantation

Antigen specificNeonatal tolerization

Enhancing (anti-allogeneic) antibodiesAnti-idiotype antibodies to receptors on T

cellBlood transfusion in human kidney

transplant

Page 27: Organ Transplantation